Latest Strategic Asset Sales News

Kula Gold has agreed to sell its Westonia Project to Forrestania Resources for an upfront $500,000 plus a $1 million contingent payment tied to resource discovery. This move sharpens Kula’s focus on advancing its Mt Palmer Gold Project.

Thor Energy has agreed to sell its 75% stake in the FRAM Joint Venture to Tivan Limited for A$8.75 million, significantly strengthening its balance sheet and accelerating its focus on natural hydrogen and helium exploration in South Australia.

Emu NL has agreed to sell its Badja Gold Project subsidiary for AUD 3.5 million, redirecting focus and funds to its promising Yataga Copper Project in Queensland.

Rapid Critical Metals has agreed to sell its Ingersoll project and completed the sale of Tin Mountain, both in South Dakota, to Iris Metals, receiving a mix of shares and cash payments.

TasFoods narrowed its half-year loss by 29% despite a 21% drop in sales amid persistent poultry oversupply and discounted pricing. Strategic asset sales and cost-cutting efforts aim to stabilize the business in a challenging market.

Eden Innovations Ltd reported a 21% revenue increase driven by global sales growth, yet its net loss widened significantly due to prior year asset revaluations and ongoing operational costs. The company is undertaking major financial restructuring including a share consolidation and rights issue to stabilize its balance sheet.

MPower Group Limited has announced a binding agreement to sell its main renewable energy assets for approximately $19 million, reporting a net loss of $4.1 million for FY2025 largely due to discontinued operations.

Waypoint REIT delivered stable first-half earnings with a 4.7% rise in net tangible assets per security and increased its FY25 distributable earnings guidance, supported by ongoing asset sales and Viva Energy’s OTR conversions.

Next Science reports a 42% improvement in adjusted EBITDA loss for 1H FY25 despite a 7% dip in product sales, while shareholders approve a major asset sale to OSARTIS GmbH.

Next Science Limited reported a 7% revenue decline and a 20% reduction in net loss for H1 2025, alongside a major $50 million asset sale agreement with OSARTIS GmbH. The transaction, approved by shareholders, signals a strategic pivot for the biofilm-focused medical device company.

Wellard Limited reported a net profit of US$1.3 million for FY2025, driven by operational improvements and strategic asset sales. With the sale of its last livestock vessels completed, the company plans to delist from the ASX and return surplus cash to shareholders.

OM Holdings reported a slight revenue increase in the first half of 2025 but faced a loss due to falling ferrosilicon prices, while maintaining strong cash flow and preparing key asset sales.